Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and CapecitabineJavier Cortés, Mary Ann Allison, Joanne L. Blum et al.|Journal of Clinical Oncology|2010Cited by 217
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studiesChris Twelves, Ahmad Awada|Breast Cancer Research and Treatment|2014Cited by 214